Pre-earnings options volume in Viking Therapeutics is normal with puts leading calls 10:9. Implied volatility suggests the market is anticipating a move near 13.6%, or $6.90, after results are released. Median move over the past eight quarters is 4.9%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- VKTX Earnings this Week: How Will it Perform?
- B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
- Biotech Alert: Searches spiking for these stocks today
- Viking Therapeutics call volume above normal and directionally bullish